148 related articles for article (PubMed ID: 9608068)
1. [Cyclosporine in inflammatory bowel disease].
Colomina Avilés J; Pascual Pérez R; Ortuño Cortés J; García García A; Del Pino Cuadrado J
An Med Interna; 1998 Apr; 15(4):214-8. PubMed ID: 9608068
[TBL] [Abstract][Full Text] [Related]
2. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
Markowitz J; Grancher K; Mandel F; Daum F
Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporine for severe ulcerative colitis.
Pham CQ; Efros CB; Berardi RR
Ann Pharmacother; 2006 Jan; 40(1):96-101. PubMed ID: 16368919
[TBL] [Abstract][Full Text] [Related]
5. [Immunotherapy of inflammatory bowel diseases].
Wichan P; Chojnacki J; Wojtuń S
Pol Merkur Lekarski; 2004; 17 Suppl 1():40-3. PubMed ID: 15603345
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive drugs in the treatment of inflammatory bowel disease.
Aranda R; Horgan K
Semin Gastrointest Dis; 1998 Jan; 9(1):2-9. PubMed ID: 9547850
[TBL] [Abstract][Full Text] [Related]
7. Optimizing therapy for inflammatory bowel disease.
Robinson M
Am J Gastroenterol; 1997 Dec; 92(12 Suppl):12S-17S. PubMed ID: 9395347
[TBL] [Abstract][Full Text] [Related]
8. General principles of medical therapy of inflammatory bowel disease.
Friedman S
Gastroenterol Clin North Am; 2004 Jun; 33(2):191-208, viii. PubMed ID: 15177534
[TBL] [Abstract][Full Text] [Related]
9. The state of the art in the management of inflammatory bowel disease.
Hanauer SB; Present DH
Rev Gastroenterol Disord; 2003; 3(2):81-92. PubMed ID: 12776005
[TBL] [Abstract][Full Text] [Related]
10. Review article: monitoring of immunomodulators in inflammatory bowel disease.
Aberra FN; Lichtenstein GR
Aliment Pharmacol Ther; 2005 Feb; 21(4):307-19. PubMed ID: 15709982
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory bowel disease: current therapeutic options.
Domènech E
Digestion; 2006; 73 Suppl 1():67-76. PubMed ID: 16498254
[TBL] [Abstract][Full Text] [Related]
12. A review of infliximab use in ulcerative colitis.
Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine and inflammatory bowel disease: buying time.
Meijssen MA
Mediators Inflamm; 1998; 7(3):145-7. PubMed ID: 9705599
[TBL] [Abstract][Full Text] [Related]
14. Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine.
Su C; Lichtenstein GR
Gastroenterol Clin North Am; 2004 Jun; 33(2):209-34, viii. PubMed ID: 15177535
[TBL] [Abstract][Full Text] [Related]
15. Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine.
Korelitz BI; Mirsky FJ; Fleisher MR; Warman JI; Wisch N; Gleim GW
Am J Gastroenterol; 1999 Nov; 94(11):3248-53. PubMed ID: 10566724
[TBL] [Abstract][Full Text] [Related]
16. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate.
Sandborn WJ
Am J Gastroenterol; 1996 Mar; 91(3):423-33. PubMed ID: 8633486
[No Abstract] [Full Text] [Related]
17. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].
Dejaco C; Gasché C; Reinisch W; Moser G; Novacek G; Tillinger W; Vogelsang H; Gangl A
Wien Klin Wochenschr; 1998 Sep; 110(16):579-84. PubMed ID: 9782579
[TBL] [Abstract][Full Text] [Related]
18. [Aminosalicylates and steroids in the treatment ot chronic inflammatory bowel diseases--consensus paper of the Working Group for Chronic Inflammatory Bowel Diseases of the OGGH].
Dejaco C; Haas T; Kirchgatterer A; Miehsler W; Wenzl H; Knoflach P; Petritsch W; Vogelsang H; Reinisch W; Tilg H
Z Gastroenterol; 2006 Jun; 44(6):525-38; discussion 539. PubMed ID: 16773519
[TBL] [Abstract][Full Text] [Related]
19. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
Fellermann K; Ludwig D; Stahl M; David-Walek T; Stange EF
Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045
[TBL] [Abstract][Full Text] [Related]
20. Review article: treatment algorithms to maximize remission and minimize corticosteroid dependence in patients with inflammatory bowel disease.
Panaccione R; Rutgeerts P; Sandborn WJ; Feagan B; Schreiber S; Ghosh S
Aliment Pharmacol Ther; 2008 Sep; 28(6):674-88. PubMed ID: 18532990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]